This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Roche Molecular Systems, Inc.. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Martin Bengtsson: Innovator in mRNA Quantification
Introduction
Martin Bengtsson is a notable inventor based in Limhamn, Sweden. He has made significant contributions to the field of molecular biology, particularly in the area of mRNA quantification. His innovative approach has led to the development of a patented method that enhances the efficiency of RNA analysis.
Latest Patents
Bengtsson holds a patent for a method titled "Lysis and reverse transcription for mRNA quantification." This invention outlines a process for performing RT-PCR to amplify target RNA. The method includes several key steps: lysis of a cellular sample using a lysis buffer containing Guanidine Thiocyanate, dilution of the sample to a specific concentration, reverse transcription with a mixture of cDNA synthesis primers, and real-time monitoring of amplification through thermocycling. Notably, all these steps are conducted in the same vessel, streamlining the process.
Career Highlights
Martin Bengtsson is currently employed at Roche Molecular Systems, Inc., where he continues to advance research in molecular diagnostics. His work has been instrumental in improving techniques for RNA analysis, which is crucial for various applications in medical research and diagnostics.
Collaborations
Bengtsson collaborates with esteemed colleagues, including Anders Stahlberg and Linda Stroembom. Their combined expertise contributes to the innovative research environment at Roche Molecular Systems, Inc.
Conclusion
Martin Bengtsson's contributions to mRNA quantification through his patented method exemplify the impact of innovation in molecular biology. His work not only enhances research capabilities but also paves the way for advancements in medical diagnostics.